ReP USP - Resultado da busca

Filtros : "He, Yi" "Ronsein, Graziella Eliza" Removido: "Colli, Walter" Limpar

Filtros

Artigo de periodico
Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles (2020)
He, Yi; Ronsein, Graziella Eliza ; Tang, Chongren; Jarvik, Gail P; Davidson, W. Sean; Kothari, Vishal; Song, Hyun D; Segrest, Jere P; Bornfeldt, Karin E; Heinecke, Jay W
Source: Circulation Research. Unidade: IQ
Subjects: DIABETES MELLITUS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HE, Yi et al. Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles. Circulation Research, v. 127, n. 9, p. 1198–1210, 2020Tradução . . Disponível em: https://doi.org/10.1161/CIRCRESAHA.120.317178. Acesso em: 30 set. 2024.
APA
He, Y., Ronsein, G. E., Tang, C., Jarvik, G. P., Davidson, W. S., Kothari, V., et al. (2020). Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles. Circulation Research, 127( 9), 1198–1210. doi:10.1161/CIRCRESAHA.120.317178
NLM
He Y, Ronsein GE, Tang C, Jarvik GP, Davidson WS, Kothari V, Song HD, Segrest JP, Bornfeldt KE, Heinecke JW. Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles [Internet]. Circulation Research. 2020 ; 127( 9): 1198–1210.[citado 2024 set. 30 ] Available from: https://doi.org/10.1161/CIRCRESAHA.120.317178
Vancouver
He Y, Ronsein GE, Tang C, Jarvik GP, Davidson WS, Kothari V, Song HD, Segrest JP, Bornfeldt KE, Heinecke JW. Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles [Internet]. Circulation Research. 2020 ; 127( 9): 1198–1210.[citado 2024 set. 30 ] Available from: https://doi.org/10.1161/CIRCRESAHA.120.317178
Artigo de periodico
Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone (2016)
Ronsein, Graziella Eliza ; Reyes Soffer, Gissette; He, Yi; Oda, Michael; Ginsberg, Henry; Heinecke, Jay W
Source: Molecular e Cellular Proteomics. Unidade: IQ
Subjects: APOLIPOPROTEÍNAS, LIPOPROTEÍNAS HDL, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RONSEIN, Graziella Eliza et al. Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone. Molecular e Cellular Proteomics, v. 15, n. 3, p. 1083-1093, 2016Tradução . . Disponível em: https://doi.org/10.1074/mcp.M115.054528. Acesso em: 30 set. 2024.
APA
Ronsein, G. E., Reyes Soffer, G., He, Y., Oda, M., Ginsberg, H., & Heinecke, J. W. (2016). Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone. Molecular e Cellular Proteomics, 15( 3), 1083-1093. doi:10.1074/mcp.M115.054528
NLM
Ronsein GE, Reyes Soffer G, He Y, Oda M, Ginsberg H, Heinecke JW. Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone [Internet]. Molecular e Cellular Proteomics. 2016 ; 15( 3): 1083-1093.[citado 2024 set. 30 ] Available from: https://doi.org/10.1074/mcp.M115.054528
Vancouver
Ronsein GE, Reyes Soffer G, He Y, Oda M, Ginsberg H, Heinecke JW. Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone [Internet]. Molecular e Cellular Proteomics. 2016 ; 15( 3): 1083-1093.[citado 2024 set. 30 ] Available from: https://doi.org/10.1074/mcp.M115.054528

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024